Macrophages and dendritic cells play an important role in regulating B cell responses including proliferation to antigens such as TNP-Ficoll and TNP-Brucella abortus. However, the mechanisms and molecule(s) which regulate these processes are relatively undefined. In this report, we show that human macrophages generated in vitro strongly co-stimulate proliferation 
Introduction
Earlier in vitro studies suggested that the TI B cell response in mice to TNP-haptenated antigens such as TNP-Ficoll, TNP-LP and TNP-Brucella abortus directly required macrophages (12) (13) (14) (15) . Interestingly, IL-1 appeared to substitute for the requirement of macrophages in B cell responses to TI antigens. In addition, IL-1-secreting cells reconstitute the response of macrophage-depleted splenic cells to TI antigens (15) .
A newly characterized tumor necrosis factor (TNF) ligand-receptor system has recently been implicated in the regulation of both TI and TD immune responses. B cell activating factor belonging to the TNF family (BAFF; also known as TALL-1, THANK, BLyS and zTNF4) is a novel TNF ligand superfamily member which is a potent regulator of B cell development and function (16) (17) (18) (19) (20) . BAFF protein is expressed by myeloid lineage cells and exists as both cell surface-associated and soluble, released forms (19, 21) . BAFF binds to three distinct TNF receptors: TACI (transmembrane activator and CAML interactor), BCMA (B cell maturation antigen) and BAFF-R/BR3 (BLyS receptor 3) (20, (22) (23) (24) (25) (26) . Two of these receptors, TACI and BCMA, also bind another TNF ligand which shares about 50% sequence homology in its extracellular region with BAFF, known as APRIL, TRDL-1 or TALL-2 (17, (27) (28) (29) (30) . Like BAFF, APRIL is also released as a biologically active protein from cells (31) .
Overexpression or injection of BAFF increases MZ B cell numbers and serum Ig levels in mice (32) . Furthermore, TACI-deficient mice have defective responses to TI-2 antigens (33, 34) .
In addition to its role in T-independent immune responses, BAFF also appears to modestly enhance T-dependent immune responses (35) .
In this study, we investigated a potential role for human macrophages in directly enhancing proliferation of human tonsillar B cells. We show that human macrophages directly enhance proliferation of human B cells triggered via their B cell antigen receptor (BCR) but not For personal use only. on October 17, 2017 . by guest www.bloodjournal.org From CD40, a process which requires soluble molecule(s). Moreover, we show that macrophage-and DC-regulated BCR-induced human B cell proliferat ion is inhibited by TACI -Ig, demonstrating a requirement for one or more of the TACI ligands, BAFF and/or APRIL. Consistent with a major role for BAFF, macrophages released BAFF at doses sufficient to maximally co-stimulate BCRinduced B cell proliferation. Moreover, immunodepletion of APRIL did not block macrophage enhancement of BCR-induced B cell proliferation.
In summary, our studies using human cells suggest that macrophages directly regulate B cell proliferation via the TNF ligand, BAFF, and support the idea that macrophages may play an important accessory role during TI immune responses.
For personal use only. on October 17, 2017 . by guest www.bloodjournal.org From positive selection with magnetic anti-CD14 microbeads according to the manufacturer's instructions (Miltenyi Biotech, Auburn, CA). For human monocyte-derived macrophages (subsequently referred to as "macrophages"), CD14
+ cells (1 x 10 6 /ml) were cultured in complete RPMI 1640 medium containing 100 ng/ml M-CSF at 37 o C in a humidified incubator for 6-8 days. Macrophage preparations were greater than 95% CD14 + and were also mannose receptor (MR) + , CD71 + and CD3 -and many of the cells morphologically appeared spindle-like and adherent. Human monocyte-derived DCs (subsequently referred to as "DCs") were generated in vitro from CD14 + cells cultured with GM-CSF (100 ng/ml), IL-4 (30 ng/ml) and 2-mercaptoethanol (50 µM) for up to 7 days and were greater than 95% CD14 -and strongly CD1a + (36) .
Isolation of Dense Human Tonsillar B Cells
Dense B lymphocytes were isolated from human tonsils derived from different individual donors by sheep erythrocyte rosetting to deplete T cells and percoll density gradient centrifugation as described (37) . These cells were >95% CD20 + and >70% naïve IgD + CD38 -B cells and were the source of all "B cells" used in this study.
B Cell Proliferation Assays
Macrophages, DCs or monocytes (0.3-5 x 10 4 ) or macrophage-conditioned culture medium (MCCM) were cultured for 72 hr with dense tonsillar B cells (2 x 10 5 ) in the presence of antiIgM (10 µg/ml), CD40 (G28-5) mAb (250 ng/ml) or soluble human CD40L (100 ng/ml) in the presence of enhancer (1 µg/ml) as described by the manufacturer in 96-well flat-bottomed polystyrene culture plates (Becton Dickinson, Franklin Lakes, NJ). Cells were incubated for the 
Immunodepletion of Macrophage Conditioned Culture Medium
Recombinant APRIL or MCCM were incubated for 3 hr at 4 0 C with constant mixing with either 0-10 µg/ml rabbit anti-human APRIL polyclonal IgG or normal rabbit IgG. Protein A-sepharose beads (30 µl packed beads) were added for the final 90 min to bind immune complexes. After centrifugation at 14000 x g for 5 min at 4 0 C, immunodepleted supernatants were sterile filtered (0.2 µm) and co-cultured with B cells in the presence of anti-IgM (10 µg/ml) as described above.
Immunoblotting
Whole cell lysates were prepared from approximately 5 x 10 6 cells as described (38 
Results

Myeloid Lineage Cells Enhance BCR-stimulated Human B Cell Proliferation
Earlier studies have shown that monocytes and different populations of in vitro -generated human DCs directly enhance the proliferation of CD40-activated B cells (39) (40) (41) . Since macrophages represent another discrete myeloid cell lineage which interacts with B cells particularly in the splenic MZ (7), we were interested in testing whether monocyte-derived macrophages For personal use only. on October 17, 2017. by guest www.bloodjournal.org From
Fig. 1
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Macrophages and DCs Costimulate B Cell Proliferation via Soluble Factor(s)
We then tested whether the effect of macrophages on BCR-stimulated B cell proliferation could be mediated by a soluble factor(s), by incubating macrophage-conditioned culture medium (MCCM) with B cells in the presence or absence of anti-IgM. In the absence of BCR ligation, MCCM, like macrophages (Fig. 1A) , did not significantly increase B cell proliferation ( Fig. 2A) .
However, in the presence of anti-IgM, MCCM strongly increased B cell proliferation in a dosedependent manner up to 5-fold ( Fig. 2A) . This effect was independent of M-CSF in the culture media, which did not itself enhance BCR-induced B cell proliferation ( Fig. 2A ).
In addition, we compared the stimulatory effects of macrophages separated from B cells (Fig. 2B) . Similarly, DCs cultured apart from B cells also increased BCR-induced B cell proliferation (data not shown). These data suggest that direct cell contact is not essential for macrophages and DCs to increase B cell proliferation. Thus, the ability of both macrophages and DCs to enhance BCR-dependent human B cell proliferation is mediated by a soluble factor(s).
For 
TACI-Ig Inhibits Macrophage-and DC-induced Costimulation of B Cell Proliferation
Two novel, related TNF superfamily members, BAFF and APRIL, bind to TACI and can be blocked by soluble TACI-Ig (20) . Myeloid lineage cells express the highest levels of BAFF (19, 21) . While BAFF is constitutively expressed by macrophages as both membrane-associated and secreted forms, it is undetectable on the surface of myeloid DCs (21 (27) .
In order to test whether either BAFF and/or APRIL plays a role in macrophage-induced B cell costimulation, we preincubated TACI-Ig with either macrophages or MCCM prior to co-culture with B cells. Under experimental conditions where TACI-Ig blocked BAFF-induced B cell costimulation, TACI-Ig but not a control IgG 1 fusion protein also completely inhibited macrophage-mediated B cell proliferation (Fig. 3A) . Similarly, B cell co-stimulation via antiIgM and MCCM was also strongly blocked by a TACI-Ig but not a control IgG 1 fusion protein (Fig. 3A) . Anti-IgM did not increase thymidine incorporation by macrophages themselves. This result excludes the possibility that proliferation of the macrophages accounts for the strong increase in BCR-induced B cell proliferation by macrophages (Fig. 3A) . Furthermore, TACI-Ig, but not a control IgG 1 fusion protein, also markedly inhibited DC-enhanced BCR-induced B cell proliferation (Fig. 3B) . These results show that BAFF and/or APRIL are required for macrophage-and DC-induced B cell costimulation.
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Myeloid Cells express BAFF and APRIL mRNA and Protein; Regulation by Cytokines and Bacterial Cell Wall Components
Since our results strongly suggest that a macrophage-and DC-derived TACI ligand mediates B cell costimulation, we next examined the expression of BAFF and APRIL in different human myeloid cells. Initially, RT-PCR was used to quantify relative mRNA levels.
Both BAFF and APRIL were expressed at similar relative mRNA levels in macrophages, DCs and monocytes (Fig. 4A , upper and middle panels). APRIL but not BAFF mRNA was also (16, 19, 21) . Thus, we quantified release of soluble BAFF using capture ELISA. Supernatants from M-CSF-derived macrophages contained BAFF in the range of 3-23 ng/ml during a 6-8 day incubation period from approx. 20 different donors (Fig. 4B) . Treatment of macrophages with either IL-10 or interferon-but not IL-4 enhanced BAFF levels approx. 2-to 6-fold compared to untreated controls, consistent with another study (Fig. 4C, 21 ). In addition, the Gram-positive cell wall component, peptidoglycan also moderately increased BAFF release 2-to 3-fold (Fig. 4C) .
APRIL protein was detected by immunoblotting cell lysates using an APRIL-specific polyclonal antiserum. APRIL was expressed as two distinct polypeptides of approx. 25 and 27kDa (Fig.   4D ). The existence of multiple forms of APRIL is consistent with previous studies which identified three alternatively spliced human APRIL cDNAs (TRDL-1 , TRDL-1 and TRDL-1 ) and which are predicted to encode proteins of 27.4, 25.7 and 27.1 kDa respectively (28).
Macrophages expressed high relative levels of the smaller APRIL polypeptide (APRIL-short, Fig. 4D ). This shorter APRIL species was not detected in either unstimulated monocytes, DCs or B cells (Fig. 4D) . In contrast, the larger APRIL species (APRIL-long) was expressed at low levels in B cells, but not significantly expressed in either monocytes, DCs or macrophages (Fig.   4D ). Consistent with a minor role for endogenously produced APRIL driving B cell proliferation, a TACI-Ig but not a control-Ig fusion protein partially inhibited anti-IgMstimulated B cell proliferation (Fig. 3C) . Furthermore, B cell and myelocytic leukemia tumorderived cell lines (Raji, T5-1, HL-60 and THP-1) exclusively expressed high levels of the larger APRIL species (data not shown), consistent with reported mRNA expression data (27) .
Treatment of DCs with either LPS or IFN-markedly increased levels of the smaller APRIL
For personal use only. on October 17, 2017. by guest www.bloodjournal.org From species, but not to the same levels expressed in macrophages (Fig. 4E) . Neither LPS or IFNfurther enhanced the constitutively very high levels of APRIL observed in macrophages.
BAFF strongly Costimulates BCR-but not CD40-induced Human B Cell Proliferation
Since macrophages and DCs express both BAFF and APRIL ( Fig. 4; 21) , we compared the effects of recombinant BAFF and APRIL on the proliferation of B cells. In the absence of a costimulus, soluble BAFF induced moderate increases in B cell proliferation (Fig. 5A ).
However, in the presence of anti-IgM, BAFF strongly costimulated B cell proliferation more than 10-fold (Fig. 5A) . Importantly, BAFF levels (3 ng/ml) which maximally costimulated BCRinduced B cell proliferation were within the range of BAFF levels constitutively released by (Fig. 4B) . Similar to BAFF, soluble recombinant APRIL also enhanced BCRinduced B cell proliferation 2-3-fold, but the concentrations of APRIL required to costimulate B cell proliferation were more than 50-fold higher compared to BAFF (Fig. 5B) . We also tested the effect of soluble BAFF on CD40L-induced B cell proliferation. BAFF increased CD40L-induced B cell proliferation less than 2-fold over a wide range of CD40L and BAFF concentrations (Fig. 5C ). These data correlate with our earlier results showing that macrophages and DCs only weakly augment CD40-induced proliferation of B cells (Fig. 1B) .
Fig. 5
For Assays were performed in triplicate, and results are presented as the mean ± SD from one of three similar experiments.
Macrophage-induced B Cell Proliferation does not require APRIL
In order to further distinguish between a possible role for BAFF or APRIL, we immunodepleted APRIL using an APRIL antiserum. APRIL-dependent increases in BCRinduced B cell proliferation were completely blocked by preincubation of purified recombinant APRIL with the APRIL antiserum but not control serum (Fig. 6 ). In contrast, MCCM-mediated enhancement of anti-IgM-induced B cell proliferation was unaffected following preincubation with anti-APRIL (Fig. 6) . These results together with the observation that APRIL is much less effective than BAFF in stimulating B cells and also that APRIL protein is not expressed in unstimulated DCs ( Fig. 4D and E, Fig. 5 ), strongly suggest that BAFF is the major macrophageand DC-derived factor costimulating BCR-activated human B cells.
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B Cells
Macrophage-conditioned culture supernatant or recombinant human APRIL were incubated for 3 hr at 4 0 C with constant mixing with either PBS, purified rabbit anti-human APRIL IgG or control IgG (10 µg/ml). Protein A-sepharose beads were added for the final 90 min to bind immune complexes. After centrifugation at 4 0 C, immunodepleted supernatants were sterile filtered and co-cultured with dense tonsillar B cells in the presence of anti-human IgM F(ab') 2 fragments (10 µg/ml) as described in Fig. 1 . The asterisk indicates statistically significant differences between samples within the bracketed groups (p < 0.05).
Discussion
These studies show that both human monocyte-derived macrophages and DCs directly enhance proliferation of BCR-activated human B cells via a soluble factor(s) ( Fig. 1 and 2 ).
Moreover, macrophage-and DC-induced B cell costimulation was inhibited by a TACI-Ig fusion protein (Fig. 3) , which binds two known ligands, BAFF and APRIL. While macrophages express both BAFF and APRIL protein (Fig. 4) , immunodepletion of APRIL did not block macrophageinduced B cell co-stimulation consistent with the finding that BAFF is the major factor required for the enhancement of BCR-induced B cell proliferation by macrophages (Fig. 6 ). Consistent with these results and as previously reported (21), BAFF was secreted by macrophages at levels sufficient to potently costimulate B cell proliferation ( Fig. 4 and 5) . Furthermore, BAFF was at least 50-fold more potent than APRIL in augmenting anti-IgM-dependent proliferation of tonsillar B cells (Fig. 5) . Finally, there was no correlation between the high levels of APRIL protein expressed in macrophages compared to DCs and the similar abilities of these two myeloid cell types to costimulate B cell proliferation ( Fig. 1 and 4D ). This is consistent with the model that APRIL does not play a major role in augmenting BCR-mediated B cell proliferation.
Indeed, a possible role for APRIL in regulating B cell homeostasis in vivo remains to be shown, as APRIL-deficient mice die in utero (42) . These results are also consistent with previous studies using mice deficient in various BAFF receptors, which strongly suggest a major positive regulatory role for BAFF-R, which binds only BAFF, but not TACI or BCMA, in BCR-induced B cell costimulation (25, 26, 33, 34, 43 (40, 45) , the mechanism(s) by which DCs directly costimulate B cell growth remain uncharacterized. The factor(s) described by Dubois and colleagues which enhanced B cell proliferation appeared to be both soluble and produced in a CD40-independent manner (39) . Similarly, we found using Transwells that both DCs and macrophages enhance BCR-induced B cell proliferation through the generation of a predominantly soluble factor(s) (Fig. 2) . Nevertheless, it is unlikely that BAFF is the DC-derived factor which enhances CD40-activated proliferation of human tonsillar B cells (39, 41) , since BAFF only weakly enhances CD40-induced proliferation of dense human tonsillar B cells (Fig. 5C) . In related studies, macrophages, which strongly enhanced BCR-induced proliferation ( Fig 1A) and released BAFF at levels sufficient to potently costimulate B cell proliferation (Fig. 4B) , inhibited CD40L-stimulated proliferation of B cells (Fig. 1B, data not shown) , suggesting that macrophages may differentially regulate B cell responses to TI versus TD B lymphocyte signals.
While our results suggest that APRIL does not appear to play a major role in macrophage-induced co-stimulation of B cells (Fig. 4-6 ), we show for the first time that APRIL protein is differentially expressed in myeloid lineage cells, with high constitutive levels observed
For personal use only. on October 17, 2017. by guest www.bloodjournal.org From in macrophages but not DCs or monocytes (Fig. 4D) . Our results also indicate that APRIL expression may be regulated at the post-transcriptional level, since APRIL mRNA was present in all 3 myeloid cell lineages examined, yet high levels of protein were only observed in macrophages (Fig. 4) . In addition, APRIL may be regulated post-translationally via cleavage and secretion. It is currently unknown whether endogenous APRIL is processed and released by macrophages, although recent studies using APRIL-transfected HEK293 cells show that APRIL, like BAFF, can be released as a soluble and biologically-active ligand (31) . We were unsucessful in attempts to establish an APRIL-specific ELISA using a panel of commercially-available APRIL antisera to examine its possible release by macrophages and DCs, as we and others have observed for BAFF ( Fig. 4B and C, 21 ).
While our studies were performed using dense human tonsillar human B cells, a subset of In conclusion, our results demonstrate that monocyte-derived macrophages and DCs directly enhance BCR-mediated human B cell proliferation via a soluble factor(s), which is specifically blocked by TACI-Ig.
